SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001628280-20-014346
Filing Date
2020-10-06
Accepted
2020-10-06 16:02:04
Documents
14
Period of Report
2020-02-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A ck0001576280-20200224.htm   iXBRL 8-K/A 38529
  Complete submission text file 0001628280-20-014346.txt   187748

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ck0001576280-20200224.xsd EX-101.SCH 2566
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ck0001576280-20200224_cal.xml EX-101.CAL 815
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ck0001576280-20200224_def.xml EX-101.DEF 1779
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ck0001576280-20200224_lab.xml EX-101.LAB 25236
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ck0001576280-20200224_pre.xml EX-101.PRE 13280
7 EXTRACTED XBRL INSTANCE DOCUMENT ck0001576280-20200224_htm.xml XML 12700
Mailing Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063
Business Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

IRS No.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38683 | Film No.: 201226774
SIC: 8071 Services-Medical Laboratories
Office of Life Sciences